Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation

Practical tools to identify short children born small-for-gestational-age eligible for rhGH treatment according to Italian regulation

Abstract Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1800. The latest data from the National Registry of Growth Hormone therapy (RNAOC)...

Full description

Saved in:
Bibliographic Details
Main Authors: Gianluca Tornese (Author), Flavia Pricci (Author), Maria Chiara Pellegrin (Author), Marika Villa (Author), Daniela Rotondi (Author), Elvira Agazio (Author), Egidio Barbi (Author)
Format: Book
Published: BMC, 2019-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items